Recent advances in isatin-derived hybrids: promising multifunctional agents for drug development

Isatin-based hybrids have emerged as promising candidates in medicinal chemistry due to their broad biological activities and structural versatility. This review outlines recent developments (2020–2025) in the design of isatin hybrids targeting cancer, neurodegenerative diseases, bacterial and myco...

Full description

Saved in:
Bibliographic Details
Main Authors: Aleksandar Dimkovski, Evgenija Mihajloska, Ana Poceva Panovska
Format: Article
Language:English
Published: University Ss Cyril and Methodius in Skopje, Faculty of Pharmacy and Macedonian Pharmaceutical Association 2025-12-01
Series:Makedonsko Farmacevtski Bilten
Subjects:
Online Access:http://bulletin.mfd.org.mk/volumes/Volume%2071_2/71_2_002.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839622987741921280
author Aleksandar Dimkovski
Evgenija Mihajloska
Ana Poceva Panovska
author_facet Aleksandar Dimkovski
Evgenija Mihajloska
Ana Poceva Panovska
author_sort Aleksandar Dimkovski
collection DOAJ
description Isatin-based hybrids have emerged as promising candidates in medicinal chemistry due to their broad biological activities and structural versatility. This review outlines recent developments (2020–2025) in the design of isatin hybrids targeting cancer, neurodegenerative diseases, bacterial and mycobacterial infections, diabetes, inflammation, and viral diseases. Rational hybridization strategies have led to compounds with enhanced potency, multitarget activity, and improved pharmacokinetic profiles. Key structural modifications, especially at the N-1, C-3, and C-5 positions of the isatin core, have been crucial in optimizing biological efficacy. Several hybrids demonstrated superior activity compared to standard drugs, alongside favorable safety and pharmacodynamic and pharmacokinetic profiles. This overview highlights the therapeutic potential of isatin hybrids as versatile scaffolds for the development of next-generation multifunctional agents across diverse clinical areas.
format Article
id doaj-art-a0b6a91d5ed4436c8fdc7e43d25af152
institution Matheson Library
issn 1409-8695
1857-8969
language English
publishDate 2025-12-01
publisher University Ss Cyril and Methodius in Skopje, Faculty of Pharmacy and Macedonian Pharmaceutical Association
record_format Article
series Makedonsko Farmacevtski Bilten
spelling doaj-art-a0b6a91d5ed4436c8fdc7e43d25af1522025-07-21T09:14:36ZengUniversity Ss Cyril and Methodius in Skopje, Faculty of Pharmacy and Macedonian Pharmaceutical AssociationMakedonsko Farmacevtski Bilten1409-86951857-89692025-12-01712132510.33320/maced.pharm.bull.2025.71.02.002Recent advances in isatin-derived hybrids: promising multifunctional agents for drug developmentAleksandar Dimkovski0Evgenija Mihajloska1Ana Poceva Panovska2Ss Cyril and Methodius University in Skopje, Faculty of Pharmacy, Institute for Pharmaceutical Chemistry, Majka Tereza 47, 1000 Skopje, Republic of North MacedoniaSs Cyril and Methodius University in Skopje, Faculty of Pharmacy, Institute for Pharmaceutical Chemistry, Majka Tereza 47, 1000 Skopje, Republic of North MacedoniaSs Cyril and Methodius University in Skopje, Faculty of Pharmacy, Institute for Applied Chemistry and Pharmaceutical Analysis, Majka Tereza 47, 1000 Skopje, Republic of North MacedoniaIsatin-based hybrids have emerged as promising candidates in medicinal chemistry due to their broad biological activities and structural versatility. This review outlines recent developments (2020–2025) in the design of isatin hybrids targeting cancer, neurodegenerative diseases, bacterial and mycobacterial infections, diabetes, inflammation, and viral diseases. Rational hybridization strategies have led to compounds with enhanced potency, multitarget activity, and improved pharmacokinetic profiles. Key structural modifications, especially at the N-1, C-3, and C-5 positions of the isatin core, have been crucial in optimizing biological efficacy. Several hybrids demonstrated superior activity compared to standard drugs, alongside favorable safety and pharmacodynamic and pharmacokinetic profiles. This overview highlights the therapeutic potential of isatin hybrids as versatile scaffolds for the development of next-generation multifunctional agents across diverse clinical areas. http://bulletin.mfd.org.mk/volumes/Volume%2071_2/71_2_002.pdfisatin derivativesdrug discoverypharmacological propertiesanticancer activityneuroprotective activity
spellingShingle Aleksandar Dimkovski
Evgenija Mihajloska
Ana Poceva Panovska
Recent advances in isatin-derived hybrids: promising multifunctional agents for drug development
Makedonsko Farmacevtski Bilten
isatin derivatives
drug discovery
pharmacological properties
anticancer activity
neuroprotective activity
title Recent advances in isatin-derived hybrids: promising multifunctional agents for drug development
title_full Recent advances in isatin-derived hybrids: promising multifunctional agents for drug development
title_fullStr Recent advances in isatin-derived hybrids: promising multifunctional agents for drug development
title_full_unstemmed Recent advances in isatin-derived hybrids: promising multifunctional agents for drug development
title_short Recent advances in isatin-derived hybrids: promising multifunctional agents for drug development
title_sort recent advances in isatin derived hybrids promising multifunctional agents for drug development
topic isatin derivatives
drug discovery
pharmacological properties
anticancer activity
neuroprotective activity
url http://bulletin.mfd.org.mk/volumes/Volume%2071_2/71_2_002.pdf
work_keys_str_mv AT aleksandardimkovski recentadvancesinisatinderivedhybridspromisingmultifunctionalagentsfordrugdevelopment
AT evgenijamihajloska recentadvancesinisatinderivedhybridspromisingmultifunctionalagentsfordrugdevelopment
AT anapocevapanovska recentadvancesinisatinderivedhybridspromisingmultifunctionalagentsfordrugdevelopment